EDUCATION

      Oncology and Hematology Fellow, University                            1971-1973

        of Washington School of Medicine, Seattle, WA

      Clinical Associate, Immunophysiology Section,                          1969-1971

        Metabolism Branch, National Cancer Institute,

        National Institute of Health, Bethesda, MD

      Intern and Assistant Resident in Medicine,                                   1967-1969

        University Hospitals, Cleveland, OH

      Harvard Medical School, M.D., cum laude                                  1963-1967

      Harvard University, B.A., summa cum laude                               1959-1963

      Menlo-Atherton High School, Atherton, CA                               1956-1959

CURRENT POSITIONS

      Consulting Medical Oncologist/Hematologist, Bartlett Regional Hospital         

           Juneau, Alaska 99801                                                                  2001-present

       Emeritus Clinical Professor of Medicine, Division of Oncology    2014-present

           University of Washington School of Medicine, Seattle, WA

       Attending Physician, End of Life Washington                                2022-present

       Senior Consultant, BioPharma Consulting Services LLC and

              independent biotechnology consultation                                   2004-present

       Data Safety Monitoring Board, Seattle Cancer Care Alliance,        2014-present                                 

           Mini-Transplantation Committee, Seattle, WA

PREVIOUS POSITIONS

      Health Physician/Practitioner Consultant, Qualis Health,                  1995-2019

           Seattle, WA

       Locum Tenens, Medical Oncology/Hematology, Olympic               2002-2018

           Medical Cancer Center, Port Angeles and Sequim, WA                              

       Director of Clinical Oncology, Sonus Pharmaceuticals,                    2002-2004

           Bothell, WA

       Medical Director, Dendreon Corporation,                                          2001-2002

           3005 First Ave., Seattle, WA 98121                    

      Principal Investigator, Virginia Mason/NeoRx                                  1987-2001

           Corporation Phase I/II Therapy Trials of

           Radiolabeled Monoclonal Antibodies

Principal Investigator, Virginia Mason Community                                1993-2001

           Clinical Oncology Program (CCOP)

Physician, Section of Hematology-Oncology,                                          1981-2001

           Virginia Mason Clinic, Seattle, WA

Clinical Professor of Medicine, Division of Oncology                            1991-2014

           University of Washington School of Medicine, Seattle, WA

Associate Medical Staff, Harborview Medical Center,                            1980-2014       Seattle, WA

Data Safety Monitoring Board, Seattle Cancer Care Alliance

           trial of gene therapy in non-Hodgkin lymphoma                           2004-2013

Member, Veterans Administration Medical Center Institutional

           Review Board, Seattle, WA                                                           2008-2013

Locum Tenens, Columbia Basin Hematology Oncology                          2009

            Kennewick, WA 99336             

Locum Tenens, Seattle Cancer Care Alliance Breast Clinic                     2007

Director of Clinical Oncology, Sonus Pharmaceuticals,                           2002-2004

           Bothell, WA

Huff Clinical Research Chair in Hematology/Oncology                          2001

Translational Research Grant Recipient, Leukemia &

           Lymphoma Society                                                                        2000-2001

Physician Advisory Committee,                                                               2000-2002

           Puget Sound Ovarian Cancer Consortium

Medical Director, Virginia Mason Cancer Clinical                                 1995-2001

           Research Unit

Blue Cross of Washington & Alaska Oncology                                       1992-2001

           Investigative Advisory Panel

Executive Committee, Puget Sound Oncology                                        1986-2001

           Consortium

Medical Director, Virginia Mason Collection Center,                             1988-2001

           National Marrow Donor Program

Seattle Blood Club, Vice President                                                           1985-2007

Assistant Member (1975-78), Associate Member (1978-1980)                1975-1980

           Fred Hutchinson Cancer Research Center, Seattle, WA

Instructor (1973-74), Assistant Professor (1974-78),                                1973-1991

        Associate Professor (1978-80), Clinical Associate

        Professor (1981-91) of Medicine,

        Division of Oncology, University of Washington

       School of Medicine, Seattle, WA

LICENSURE

      Washington     #11881                                                                    

      Alaska             #4185

CERTIFICATION

      Fellow, American College of Physicians                                              1975

      Diplomate, Subspecialty of Medical Oncology,

        American Board of Internal Medicine                                                1973

      Diplomate, American Board of Internal Medicine                                1972

      Diplomate, National Board of Medical Examiners                               1968                                                         

HONORS

      Who's Who in Medicine and Healthcare                                               1994-2008

      Seattle Magazine "Top Docs"                                                                1997-1999

      Junior Faculty Clinical Fellowship, American                                      1974-1977

          Cancer Society

      Dean's prize, Harvard Medical School (for performance in                  1967

          preclinical years)

      Alpha Omega Alpha                                                                              1966

      Phi Beta Kappa                                                                                      1963

      Detur Prize, Harvard College                                                                1960

SOCIETY MEMBERSHIPS

      Fellow, American College of Physicians

      American Society of Hematology

      American Society of Clinical Oncology

COMMITTEES

      Chairman, Research Advisory Committee,

           Virginia Mason Medical Center                                                           2000-2001

      MD Anderson Community Clinical Oncology Program

           Research Base Steering Committee                                                     2000-2001

      Virginia Mason Stem Cell Transplant Committee

           Chairman                                                                                              1991-2001

      Virginia Mason Bioethics Committee                                                      1985-2001

PATENTS

Use of picoplatin to treat colorectal cancer, #8168661, May 1, 2012

EDITORIAL BOARD POSITIONS

      Bulletin of The Mason Clinic                                                                   1983-2001

      Abstracts Editorial Board, Transplantation Proceedings                          1981-1984

      Experimental Hematology                                                                        1981-1983

BIBLIOGRAPHY

  1.         Weiden PL, Epstein W, Schultz SG:  Cation transport in Escherichia coli:  VII.  Potassium requirement for phosphate uptake.  J Gen Physiol 1967;50:1641-1661.

  2.         Weiden PL, Blaese RM:  Hemolytic anemia in agammaglobulinemic chickens:  A model of autoimmune disease in immune deficiency.  J Immunol 1971;107:1004-1013.

  3.         Weiden PL, Blaese RM:  Hereditary thrombocytopenia--relation to Wiskott-Aldrich syndrome with special reference to splenectomy.  J Pediatr 1972;80:226-234.

  4.         Weiden PL, Blaese RM, Strober W, Block JB, Waldmann TA:  Impaired lymphocyte transformation in intestinal lymphangiectasia:  Evidence for at least two functionally distinct lymphocyte populations in man.  J Clin Invest 1972:51:1319-1325. 

  5.         Weiden PL, Wright SE:  Vincristine neurotoxicity.  N Engl J Med 1972;286:1369-1370.

  6.         Weiden PL, Buckner CD:  Thioridazine toxicity:  Agranulocytosis and hepatitis with encephalopathy.  JAMA 1973;224:518-520.

  7. – 243.    Available upon request        

244. Weiden PL. Pretargeted radioimmunotherapy (PRIT^ä) using an antibody-streptavidin fusion protein. Leukemia and Lymphoma, 2002; 43(10):1971-73.

245. Forero A, Weiden PL, Vose JM, Knox SJ, LoBuglio AF, Hankins J, Goris ML, Picozzi VJ, Axworthy DB, Breitz HB, Sims RB, Ghalie RG, Shen S, and Meredith RF.  Phase I trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin’s lymphoma.  Blood. 2004; 104(1):227-36.

246. Muntz HG, Malpass TW, McGonigle KF, Robertson MD, and Weiden PL. Phase II study of intraperitoneal topotecan as consolidation chemotherapy in ovarian and primary peritoneal carcinoma, Cancer 2008; 113:490-96.

247. Weiden PL.  Art of Oncology: Our Role as Patient Advocate, J Clin Oncol, 2012; 30:3983-94